New Approaches To Neuroblastoma Therapy Consortium

This study tests whether adding special immune cells (NK cells) from a healthy donor to a standard chemo-immunotherapy regimen can help children and young adults with neuroblastoma that has come back or not responded to treatment. About 62 participants aged 1 to 31 will receive t…

This study collects samples of tumor tissue, blood, and bone marrow from 1,000 children with high-risk neuroblastoma. Researchers aim to learn more about the cancer cells and find better ways to detect and track the disease. The goal is to improve future treatments and prevent th…